VEGFR2-Lytic
General Information
DRACP ID DRACP01359
Peptide Name VEGFR2-Lytic
Sequence ATWLPPRGGGKLlLKlLkkLLKlLKKK
Sequence Length 27
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
OE19 | Not available | Not available | IC50=7.1μM | WST-8 assay | 72h | Patent |
T-47D | Invasive breast carcinoma of no special type | Carcinoma | IC50=6.4μM | WST-8 assay | 72h | Patent |
BXPC-3 | Pancreatic ductal adenocarcinoma | Carcinoma | IC50=12.2μM | WST-8 assay | 72h | Patent |
U-937 | Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia | Leukemia | IC50=3.5μM | WST-8 assay | 72h | Patent |
LNCaP | Prostate carcinoma | Carcinoma | IC50=8.9μM | WST-8 assay | 72h | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity HEK293: IC50>20μM; MRC-5:>20μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification l=D-Leucine; k=D-Lysine
Chiral Mix
Physicochemical Information
Formula C118H198N32O19
Absent amino acids CDEFHIMNQSVY
Common amino acids L
Mass 283302
Pl 12.1
Basic residues 7
Acidic residues 0
Hydrophobic residues 9
Net charge 7
Boman Index -939
Hydrophobicity -20.37
Aliphatic Index 104.81
Half Life
/
Extinction Coefficient cystines 5500
Absorbance 280nm 211.54
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2011/0319336 A1
Patent Title Selective anticancer chimeric peptide.
Other Iinformation Granted Patent Family: 19s / 19ex; Family Jurisdictions: US, JP, EP, WO, CN; Legal Status: Active; Application No: 200913132580; Filed: Dec 3, 2009; Published: Dec 29, 2011; Earliest Priority: Dec 3, 2008; Granted: May 7, 2013
Other Published ID CN102238965A EP2370107A2 WO2010064207A2 WO2010064207A3